Genipin increases oxaliplatin-induced cell death through autophagy in gastric cancer

Bo Ram Kim, Yoon A. Jeong, Dae Young Kim, Jung Lim Kim, Soyeon Jeong, Yoo Jin Na, Hye Kyeong Yun, Seong Hye Park, Min Jee Jo, Hassan Ashktorab, Duane T. Smoot, Dae Hee Lee, Sang Cheul Oh

Research output: Contribution to journalArticlepeer-review

13 Citations (Scopus)


Oxaliplatin is used for treatment in combination with many drugs. However, the survival rate is still low due to side effects and drug resistance. Therefore, the combination with natural products was required for increasing efficacy and reducing side effects. Genipin, a natural product derived from the Gardenia jasminoides, associated with anti-angiogenic, anti-proliferative, hypertension, inflammatory, and the Hedgehog pathway. It is not known that genipin increases the therapeutic effect of oxaliplatin in gastric cancer. In this study, we found that genipin sensitizes oxaliplatin-induced apoptosis for the first time using colony forming assay, FACS analysis, and western blotting in gastric cancer. Additionally, genipin induced p53 expression in AGS, MKN45, and MKN28 cells. Also, genipin induced autophagy and LC3 expression. Knockdown of LC3 decreased cell death enhanced by the combination of oxaliplatin and genipin. In summary, we showed that genipin increases the oxaliplatin-induced cell death via p53-DRAM autophagy. Based on this, we suggest that genipin is a sensitizer of oxaliplatin.

Original languageEnglish
Pages (from-to)460-467
Number of pages8
JournalJournal of Cancer
Issue number2
Publication statusPublished - 2020


  • Autophagy
  • Genipin
  • Oxaliplatin
  • P53

ASJC Scopus subject areas

  • Oncology


Dive into the research topics of 'Genipin increases oxaliplatin-induced cell death through autophagy in gastric cancer'. Together they form a unique fingerprint.

Cite this